HOME › DRUGS › NATEGLINIDE
ACTIVE SUBSTANCE / INN

NATEGLINIDE

Brand name(s): STARLIX, Trazec, NATEGLINIDE, Starlix
FDA LISTED
EMA LISTED
PRESCRIPTION
LAPSED
WITHDRAWN
NDA021204
ANDA205544
ACTIVE SUBSTANCE
Nateglinide
REGULATORS
FDA · EMA
SPONSORS / MAH
TEVA PHARMS, NOVARTIS, RISING
TOTAL APPLICATIONS
5
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
NATEGLINIDEANDA077467TEVA PHARMSDiscontinued
NATEGLINIDEANDA205544RISINGPrescription
STARLIXNDA021204NOVARTISDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
StarlixNovartis Europharm LimitedWithdrawn03/04/2001Diabetes Mellitus, Type 2
TrazecNovartis Europharm Ltd.Lapsed03/04/2001Diabetes Mellitus, Type 2

FULL INTELLIGENCE ON NATEGLINIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →